Evidence map›Paper›PMID 34236012›Full record

ArticleClimacteric : the journal of the International Menopause Society2021

Differences in patient-reported hormone therapy use for menopause symptoms by provider specialty.

M E McCarty, H N Thomas

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Climacteric : the journal of the International Menopause Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M E McCartyDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.ORCID 0000-0002-4306-638X
H N ThomasDepartment of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
University of Pittsburgh Medical Center · US

Funding

U19 MIDlife in the United States-Diversity Supplement-WellsU19AG051426 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI CAROL D. RYFF · 2016 to 2026
$74.8M
STATISTICS COREP01AG020166 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI RYFF, CAROL D. · 2002 to 2015
$50.6M
Adaptation and Pilot Testing of a Mindfulness-Based Behavioral Intervention for Older Women with Low Sexual DesireK23AG052628 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI THOMAS, HOLLY NICOLE · 2017 to 2021
$939k
NIA NIH HHS K23 AG052628NIA NIH HHS P01 AG020166NIA NIH HHS U19 AG051426
6 · The paper itself

Abstract

objectiveHormone therapy (HT) is an effective treatment for menopause symptoms in select women. This study aimed to determine whether there is different prevalence of HT use based on patient report by women who see different provider specialties.

methodsThis study was a cross-sectional analysis of published data from the Survey of Midlife in the United States (MIDUS), a telephone or self-administered questionnaire of 3294 participants aged 39-90 years. Postmenopausal women were included. Self-reported HT use and provider specialty seen were each assessed by one question. Univariate logistic regression assessed factors possibly related to HT use. Variables with

resultsOf the 938 postmenopausal respondents, 720 (76%) saw a gynecologist for care. One-hundred and thirty-one (13%) women used HT for menopausal symptoms. Of women using HT, 72 (55%) saw a gynecologist. When controlling for other factors, women who saw a gynecologist had three times higher odds of using HT. The most frequently seen provider specialty was not associated with use.

conclusionsWomen who ever see a gynecologist are more likely to use HT for menopausal symptoms, but fewer women see gynecologists as they age. Generalists are the most seen provider specialty, positioning them to counsel patients about HT.

Indexed as

Estrogen Replacement TherapyMenopauseCross-Sectional StudiesFemaleHormonesHumansPatient Reported Outcome MeasuresUnited StatesHormoneshormone therapyMenopauseprovider specialty

Identifiers

PMID34236012
PMCPMC9827593
OpenAlexW3178312452

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.